{"2501.06823": {"publish_time": "2025-01-12", "title": "MEXA-CTP: Mode Experts Cross-Attention for Clinical Trial Outcome Prediction", "paper_summary": "Clinical trials are the gold standard for assessing the effectiveness and\nsafety of drugs for treating diseases. Given the vast design space of drug\nmolecules, elevated financial cost, and multi-year timeline of these trials,\nresearch on clinical trial outcome prediction has gained immense traction.\nAccurate predictions must leverage data of diverse modes such as drug\nmolecules, target diseases, and eligibility criteria to infer successes and\nfailures. Previous Deep Learning approaches for this task, such as HINT, often\nrequire wet lab data from synthesized molecules and/or rely on prior knowledge\nto encode interactions as part of the model architecture. To address these\nlimitations, we propose a light-weight attention-based model, MEXA-CTP, to\nintegrate readily-available multi-modal data and generate effective\nrepresentations via specialized modules dubbed \"mode experts\", while avoiding\nhuman biases in model design. We optimize MEXA-CTP with the Cauchy loss to\ncapture relevant interactions across modes. Our experiments on the Trial\nOutcome Prediction (TOP) benchmark demonstrate that MEXA-CTP improves upon\nexisting approaches by, respectively, up to 11.3% in F1 score, 12.2% in PR-AUC,\nand 2.5% in ROC-AUC, compared to HINT. Ablation studies are provided to\nquantify the effectiveness of each component in our proposed method.", "paper_summary_zh": "\u81e8\u5e8a\u8a66\u9a57\u662f\u8a55\u4f30\u6cbb\u7642\u75be\u75c5\u7684\u85e5\u7269\u6709\u6548\u6027\u548c\u5b89\u5168\u6027\u7684\u9ec3\u91d1\u6a19\u6e96\u3002\u9451\u65bc\u85e5\u7269\u5206\u5b50\u7684\u5ee3\u6cdb\u8a2d\u8a08\u7a7a\u9593\u3001\u9ad8\u6602\u7684\u8ca1\u52d9\u6210\u672c\u548c\u9019\u4e9b\u8a66\u9a57\u591a\u5e74\u7684\u6642\u9593\u8868\uff0c\u81e8\u5e8a\u8a66\u9a57\u7d50\u679c\u9810\u6e2c\u7684\u7814\u7a76\u7372\u5f97\u4e86\u5de8\u5927\u7684\u95dc\u6ce8\u3002\u6e96\u78ba\u7684\u9810\u6e2c\u5fc5\u9808\u5229\u7528\u85e5\u7269\u5206\u5b50\u3001\u76ee\u6a19\u75be\u75c5\u548c\u7b26\u5408\u8cc7\u683c\u6a19\u6e96\u7b49\u591a\u7a2e\u6a21\u5f0f\u7684\u6578\u64da\u4f86\u63a8\u65b7\u6210\u529f\u548c\u5931\u6557\u3002\u6b64\u4efb\u52d9\u7684\u5148\u524d\u6df1\u5ea6\u5b78\u7fd2\u65b9\u6cd5\uff08\u4f8b\u5982 HINT\uff09\u901a\u5e38\u9700\u8981\u5408\u6210\u5206\u5b50\u7684\u6fd5\u5be6\u9a57\u5ba4\u6578\u64da\u548c/\u6216\u4f9d\u8cf4\u65bc\u5148\u9a57\u77e5\u8b58\u5c07\u4ea4\u4e92\u7de8\u78bc\u70ba\u6a21\u578b\u67b6\u69cb\u7684\u4e00\u90e8\u5206\u3002\u70ba\u4e86\u89e3\u6c7a\u9019\u4e9b\u9650\u5236\uff0c\u6211\u5011\u63d0\u51fa\u4e86\u4e00\u500b\u8f15\u91cf\u7d1a\u7684\u57fa\u65bc\u6ce8\u610f\u529b\u7684\u6a21\u578b MEXA-CTP\uff0c\u4ee5\u6574\u5408\u73fe\u6210\u7684\u591a\u6a21\u5f0f\u6578\u64da\u4e26\u901a\u904e\u7a31\u70ba\u300c\u6a21\u5f0f\u5c08\u5bb6\u300d\u7684\u5c08\u7528\u6a21\u7d44\u7522\u751f\u6709\u6548\u7684\u8868\u793a\uff0c\u540c\u6642\u907f\u514d\u6a21\u578b\u8a2d\u8a08\u4e2d\u7684\u4eba\u70ba\u504f\u5dee\u3002\u6211\u5011\u4f7f\u7528\u67ef\u897f\u640d\u5931\u51fd\u6578\u6700\u4f73\u5316 MEXA-CTP\uff0c\u4ee5\u6355\u6349\u8de8\u6a21\u5f0f\u76f8\u95dc\u7684\u4ea4\u4e92\u3002\u6211\u5011\u5728\u8a66\u9a57\u7d50\u679c\u9810\u6e2c (TOP) \u57fa\u6e96\u4e0a\u7684\u5be6\u9a57\u8868\u660e\uff0c\u8207 HINT \u76f8\u6bd4\uff0cMEXA-CTP \u5206\u5225\u5728 F1 \u5206\u6578\u4e0a\u63d0\u9ad8\u4e86 11.3%\u3001PR-AUC \u4e0a\u63d0\u9ad8\u4e86 12.2%\u3001ROC-AUC \u4e0a\u63d0\u9ad8\u4e86 2.5%\u3002\u63d0\u4f9b\u4e86\u6d88\u878d\u7814\u7a76\u4f86\u91cf\u5316\u6211\u5011\u63d0\u51fa\u7684\u65b9\u6cd5\u4e2d\u6bcf\u500b\u7d44\u4ef6\u7684\u6709\u6548\u6027\u3002", "author": "Yiqing Zhang et.al.", "authors": "Yiqing Zhang, Xiaozhong Liu, Fabricio Murai", "id": "2501.06823v1", "paper_url": "http://arxiv.org/abs/2501.06823v1", "repo": "null"}}